ARQT - Company ID 0001787306
Arcutis Biotherapeutics, Inc. has filed 793 public company documents between 2019 and 2026. The most frequent type is insider trade (369 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 144 | Insider sale notice | 5mo ago2026-02-04 | - | View filing |
| 144 | Insider sale notice | 5mo ago2026-02-02 | - | View filing |
| 144 | Insider sale notice | 5mo ago2026-02-02 | - | View filing |
| 144 | Insider sale notice | 5mo ago2026-02-02 | - | View filing |
| 144 | Insider sale notice | 5mo ago2026-02-02 | - | View filing |
| 144 | Insider sale notice | 5mo ago2026-02-02 | - | View filing |
| 144 | Insider sale notice | 5mo ago2026-02-02 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 5mo ago2026-01-30 | - | View filing |
| 4 | Insider trade | 6mo ago2026-01-07 | 2026-01-05 | View filing |
| 4 | Insider trade | 6mo ago2026-01-06 | 2026-01-02 | View filing |
| 144 | Insider sale notice | 6mo ago2026-01-05 | - | View filing |
| 4 | Insider trade | 6mo ago2026-01-02 | 2025-12-31 | View filing |
| 144 | Insider sale notice | 6mo ago2026-01-02 | - | View filing |